StockLens

GRANULES vs NATCOPHARM vs BIOCON vs ALKEM: which stock is better?

Granules India Limited (GRANULES) has the highest StockLens rating in this group at 7.5/10 (Good).

MetricGRANULESNATCOPHARMBIOCONALKEM
Overall rating7.5/10 (Good)4.9/10 (Average)2.4/10 (Poor)5.8/10 (Average)
Long-term viewStrong long-term candidateNeutral (watchlist)AvoidNeutral (watchlist)
Trade biasStrong longStrong shortStrong shortShort bias
Share price₹797.50₹820.60₹361.95₹5,222.50
Market cap₹21,754 Cr₹16,098 Cr₹59,279 Cr₹62,443 Cr
P/E27.917.9121.530.2
Return on equity13.5%9.0%1.0%14.2%
Debt / equity0.170.110.420.15
Revenue growth (YoY)+20.3%-29.0%+2.2%+13.8%
1-year return+45.0%+3.5%-6.0%-8.0%

Educational information, not investment advice. Data from Yahoo Finance and NSE Indices; prices may be delayed.